Patients and methods
Results
Unadjusted analysis
TEP | TAPP |
p
| |
---|---|---|---|
Demographic parameters
| |||
Age | |||
Years ± SD | 55.04 ± 15.95 | 55.40 ± 15.71 | 0.1441 |
Range | 16–100 | 16–98 | |
Sex | |||
Male | 5862 (87.49 %) | 9441 (86.72 %) | |
Female | 838 (12.51 %) | 1446 (13.28 %) | 0.1394 |
ASA score | |||
I | 2206 (32.93 %) | 3831 (35.19 %) | |
II | 3624 (54.09 %) | 5725 (52.59 %) | |
III | 851 (12.7 %) | 1313 (12.06 %) | |
IV | 19 (0.28 %) | 18 (0.17 %) | 0.0071 |
Surgery-related parameters
| |||
Hernia type | |||
Medial | 2057 (30.7 %) | 4188 (38.47 %) | <0.0001 |
Lateral | 5274 (78.72 %) | 7364 (67.64) | <0.0001 |
Femoral | 256 (3.82 %) | 479 (4.4 %) | 0.0627 |
Scrotal | 132 (1.97 %) | 325 (2.99 %) | <0.0001 |
Defect size | |||
I (<1.5 cm) | 1336 (19.94 %) | 1852 (17.01 %) | |
II (1.5–3 cm) | 4094 (61.1 %) | 6901 (63.39 %) | |
III (>3 cm) | 1270 (18.96 %) | 2134 (19.6 %) | <0.0001 |
Mean | SD | Min | Max | Median |
p
| |
---|---|---|---|---|---|---|
Duration of operation (min) | ||||||
TEP | 48.53 | 21.52 | 20 | 275 | 45 | <0.0001 |
TAPP | 52.62 | 23.58 | 20 | 274 | 47 | |
Length of stay (days) | ||||||
TEP | 1.88 | 2.19 | 1 | 63 | 2 | <0.0001 |
TAPP | 1.93 | 2.22 | 1 | 64 | 2 |
Unadjusted analysis | TEP | TAPP |
p
|
---|---|---|---|
Intraoperative complications | 80 (1.19 %) | 152 (1.40) | 0.2763 |
Bleeding | 53 (0.79 %) | 108 (0.99 %) | 0.1922 |
Injuries (total) | 42 (0.63 %) | 77 (0.71 %) | 0.5705 |
Vascular | 16 (0.24 %) | 34 (0.31 %) | 0.4662 |
Bladder | 3 (0.04 %) | 15 (0.14 %) | 0.0867 |
Bowel | 4 (0.06 %) | 14 (0.13 %) | 0.2256 |
Nerve | 1 (0.01 %) | 0 (0) | 0.381 |
Postoperative complications | 114 (1.70 %) | 432 (3.97 %) | <0.0001 |
Bleeding | 77 (1.15 %) | 89 (0.82 %) | 0.03 |
Intestinal lesion | 0 (0) | 4 (0.04 %) | 0.3048 |
Impaired wound healing | 9 (0.13 %) | 10 (0.09 %) | 0.4798 |
Seroma | 34 (0.51 %) | 333 (3.06 %) | <0.0001 |
Infection | 3 (0.04 %) | 4 (0.04 %) | 1 |
Intestinal obstruction | 0 (0) | 6 (0.06 %) | 0.0891 |
Reoperation | 55 (0.82 %) | 98 (0.90 %) | 0.6165 |
General complications | 65 (0.97 %) | 137 (1.26 %) | 0.0935 |
Fever | 1 (0.01 %) | 12 (0.11 %) | 0.0228 |
Diarrhea | 0 (0) | 4 (0.04 %) | 0.3048 |
Coronary heart disease | 0 (0) | 22 (0.20 %) | <0.0001 |
Exitus letalis | 0 (0) | 5 (0.05 %) | 0.1641 |
Multivariable analysis
Parameter | Category | Intraoperative complications | |
---|---|---|---|
OR [95 % CI] |
p
| ||
EHS medial | Yes versus no | 0.607 [0.451; 0.816] | 0.0001 |
OP method | TAPP versus TEP | 1.214 [0.923; 1.596] | 0.1648 |
Age* | 1.061 [0.962; 1.170] | 0.2339 | |
Defect size | I (<1.5 cm) versus III (>3 cm) | 0.950 [0.614; 1.470] | 0.5775 |
II (1.5–3 cm) versus III (>3 cm) | 0.851 [0.614; 1.180] | ||
Sex | Male versus female | 1.248 [0.819; 1.901] | 0.3032 |
ASA | II versus I | 1.059 [0.770; 1.455] | 0.9110 |
III versus I | 1.189 [0.746; 1.897] | ||
IV versus I |
Parameter | Category | Postoperative general complications | |
---|---|---|---|
OR [95 % CI] |
p
| ||
ASA | II versus I | 1.028 [0.699; 1.511] | <0.0001 |
III versus I | 2.599 [1.645; 4.107] | ||
IV versus I | 4.329 [0.970; 19.322] | ||
Age* | 1.249 [1.116; 1.398] | 0.0001 | |
EHS medial | Yes versus no | 0.577 [0.353; 0.942] | 0.0279 |
EHS lateral | Yes versus no | 0.586 [0.352; 0.976] | 0.0401 |
OP method | TAPP versus TEP | 1.315 [0.974; 1.775] | 0.0738 |
Defect size | I (<1.5 cm) versus III (>3 cm) | 1.232 [0.761; 1.996] | 0.6148 |
II (1.5–3 cm) versus III (>3 cm) | 1.016 [0.713; 1.447] | ||
EHS femoral | Yes versus no | 0.723 [0.327; 1.598] | 0.4225 |
Sex | Male versus female | 1.108 [0.709; 1.731] | 0.6532 |
EHS scrotal | Yes versus no | 0.912 [0.411; 2.027] | 0.0001 |
Parameter | Category | Postoperative surgical complications | |
---|---|---|---|
OR [95 % CI] |
p
| ||
OP method | TAPP versus TEP | 2.323 [1.882; 2.866] | <0.0001 |
Defect size | I (<1.5 cm) versus III (>3 cm) | 0.439 [0.313; 0.615] | <0.0001 |
II (1.5–3 cm) versus III (>3 cm) | 0.712 [0.582; 0.872] | ||
EHS scrotal | Yes versus no | 2.170 [1.501; 3.137] | <0.0001 |
Age* | 1.135 [1.062; 1.213] | 0.0002 | |
EHS medial | Yes versus no | 0.610 [0.458; 0.811] | 0.0007 |
EHS lateral | Yes versus no | 0.655 [0.490; 0.876] | 0.0043 |
ASA | II versus I | 1.097 [0.883; 1.363] | 0.2321 |
III versus I | 1.135 [0.834; 1.545] | ||
IV versus I | 3.075 [1.023; 9.247] | ||
Sex | Male versus female | 1.120 [0.832; 1.509] | 0.4547 |
EHS femoral | Yes versus no | 1.116 [0.700; 1.779] | 0.6449 |
Parameter | Category | Reoperation | |
---|---|---|---|
OR [95 % CI] |
p
| ||
ASA | II versus I | 1.074 [0.709; 1.627] | 0.0153 |
III versus I | 1.845 [1.075; 3.166] | ||
IV versus I | 5.656 [1.232; 25.955] | ||
Defect size | I (<1.5 cm) versus III (>3 cm) | 0.423 [0.227; 0.787] | 0.0135 |
II (1.5–3 cm) versus III (>3 cm) | 0.658 [0.454; 0.954] | ||
EHS scrotal | Yes versus no | 1.988 [1.007; 3.922] | 0.0478 |
EHS medial | Yes versus no | 0.720 [0.436; 1.188] | 0.1986 |
Age* | 1.054 [0.932; 1.192] | 0.3990 | |
OP method | TAPP versus TEP | 1.097 [0.786; 1.533] | 0.5855 |
EHS femoral | Yes versus no | 0.849 [0.318; 2.262] | 0.7431 |
EHS lateral | Yes versus no | 0.918 [0.540; 1.560] | 0.7528 |
Sex | Male versus female | 1.009 [0.586; 1.735] | 0.9754 |